Spero Therapeutics Inc (SPRO)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -285.736 | -85.961 | -37.452 | -51.827 | -60.319 | -55.316 | -31.375 | 14.848 |
| Return on Equity (%) | 88.282 | -258.181 | -41.494 | -63.987 | -75.774 | -81.475 | -56.527 | 24.948 |
| Return on Invested Capital (%) | 97.081 | -238.097 | -43.094 | -68.344 | -80.094 | -84.118 | -55.218 | 36.361 |
| Operating Margin (%) | -9743.582 | -2015.462 | -1050.479 | -335.73 | -839.014 | -481.025 | -81.874 | 24.478 |
| Net Profit Margin (%) | -8933.731 | -2329.308 | -1050.479 | -335.73 | -839.014 | -491.652 | -86.742 | 21.975 |
| Book Value Per Share | -147.009 | 5.913 | 6.733 | 3.886 | 4.512 | 2.725 | 1.447 | 2.017 |
| Earnings Per Share | -89.337 | -3.208 | -2.421 | -3.175 | -2.675 | -2.77 | -0.885 | 0.43 |
| Cash Per Share | 30.791 | 6.075 | 1.981 | 1.549 | 2.912 | 3.475 | 2.08 | 1.44 |
| Working Capital Per Share | 14.788 | 5.839 | 6.504 | 3.582 | 4.265 | 4.296 | 1.752 | 1.774 |
| Operating Profit Per Share | 1 | 0.138 | 0.231 | 0.946 | 0.319 | 0.563 | 1.02 | 1.958 |
| EBIT Per Share | -97.436 | -2.776 | -2.421 | -3.175 | -2.675 | -2.77 | -0.885 | 0.479 |
| EBITDA Per Share | -97.436 | -2.776 | -2.421 | -3.175 | -2.675 | -2.77 | -0.885 | 0.479 |
| Free Cash Flow Per Share | -87.755 | -3.231 | -2.304 | -3.197 | -2.696 | -2.79 | -0.898 | 0.423 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 335k | 14.37M | 17.21M | 19.19M | 29.26M | 32.39M | 52.46M | N/A |
| Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 42.86M | 52.46M | 52.57M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | -641.179 | N/A | N/A | N/A | -136.711 | N/A |
| Net Profit Margin (%) | N/A | N/A | -641.179 | N/A | N/A | N/A | -136.711 | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 69.45M |
| Price to Earnings Ratio | 3.03 |
| Price to Sales Ratio | 0.67 |
| Price to Cash Ratio | 0.91 |
| Price to Book Ratio | 0.65 |
| Dividend Yield | - |
| Shares Outstanding | 54.05M |
| Average Volume (1 week) | 106.04k |
| Average Volume (1 Month) | 134.14k |
| 52 Week Change | 13.82% |
| 52 Week High | 1.89 |
| 52 Week Low | 0.99 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
